Rising Yellow Fever Cases Trigger Health Emergency in the Americas

The World Health Organization (WHO) has issued a strengthened call to action for countries across the Americas to bolster preventative measures against yellow fever. This comes as the disease experiences a resurgence, with cases appearing in areas where they haven’t been historically reported, extending beyond the Amazon region.

A Significant Increase in Infections

Data from the Pan American Health Organization (OPS) and WHO reveals a concerning trend. In 2025, 346 human cases of yellow fever were confirmed across seven American countries, resulting in 143 deaths. This represents a 5.6-fold increase compared to the 61 cases reported in 2024.

Early 2026 continues to show elevated numbers, with 34 confirmed cases and 15 deaths reported between epidemiological weeks 1 and 7 (January and February). The most affected countries include Bolivia, Colombia, Peru, and Venezuela.

Geographic Spread and Emerging Risks

The expansion of yellow fever into previously unaffected regions is a key concern. The presence of Aedes aegypti mosquitoes in urban areas further exacerbates the risk of transmission in densely populated areas. This shift demands a reassessment of public health strategies.

The Severity of Yellow Fever

Yellow fever is a viral disease transmitted by mosquitoes. Severe cases can be fatal in up to 50% of instances, leading to organ failure and severe hemorrhaging. The National Institutes of Health highlights the potential for life-threatening complications.

WHO Recommendations and Global Response

In response to the escalating situation, the WHO and OPS are urging member states to prioritize several key actions:

  • Strengthened Surveillance: Enhanced monitoring systems are crucial for early detection and rapid response.
  • Intensified Vaccination: Expanding vaccination coverage among at-risk populations is paramount.
  • Traveler Protection: Ensuring travelers to affected areas are informed and protected through vaccination.
  • Clinical Management: Improving the capacity for clinical management of severe cases.
  • Vaccine Reserves: Maintaining adequate vaccine stockpiles to facilitate a swift response to potential outbreaks.

Understanding the Disease

Yellow fever’s initial symptoms include fever, headache, body aches, nausea, vomiting, and weakness. These symptoms typically subside within three to four days. However, approximately 15% of infected individuals develop a severe form of the disease, characterized by recurring high fever, jaundice, vomiting, bleeding, organ failure, and shock. The mortality rate for those progressing to this stage is around 50% within seven to ten days.

The incubation period for yellow fever ranges from three to six days.

FAQ: Yellow Fever – What You Need to Know

  • What is yellow fever? A viral disease transmitted by mosquitoes, preventable through vaccination.
  • How serious is it? Severe cases can be fatal in up to 50% of patients.
  • Is there a treatment? Currently, there is no specific antiviral treatment available.
  • How can I protect myself? Vaccination is the most effective preventative measure.

Pro Tip: If you are traveling to an area with a risk of yellow fever, consult your doctor about vaccination at least 10 days before your trip.

Stay informed and grab preventative measures to protect yourself and your community. For more information, visit the World Health Organization’s Yellow Fever page.